Neuroendocrine Tumors

DBCOND0029892Endocrine System DiseasesNeoplasms

Neuroendocrine Tumors is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Neuroendocrine Tumor · Neuroendocrine Cancer · Neuroendocrine Tumours · Neuroendocrine Neoplasms · Neuroendocrine Tumour
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0027590ICD-10D3A.8SNOMED CT1286767006MedDRA10052399UMLSC0206695

What you can answer from here — as of October 21, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
478Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Neuroendocrine Tumors share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In